Portfolio Holdings Detail for ISIN IE00BYXG2H39

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	BTEC(USD) LSE
ETF Ticker	BTEK(GBP) LSE
ETF Ticker	2B70(EUR) F
ETF Ticker	2B70.DE(EUR) CXE
ETF Ticker	BTEC.LS(USD) CXE
ETF Ticker	BTEK.LS(GBP) CXE
ETF Ticker	BTEC.L(GBP) LSE
ETF Ticker	BTEK.L(GBP) LSE

Holdings detail for TYRA

Show aggregate TYRA holdings

News associated with TYRA

Brokerages Set Tyra Biosciences, Inc. (NASDAQ:TYRA) PT at $31.86

Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Free Report) have earned a consensus rating of “Buy” from the seven research firms that are covering the stock, Marketbeat reports. Six investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month […] - 2025-09-17 02:26:46

Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Consensus Recommendation of “Buy” by Brokerages

Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Free Report) has received an average rating of “Buy” from the six research firms that are covering the stock, Marketbeat reports. Six investment analysts have rated the stock with a buy rating. The average 12-month target price among brokers that have issued a report on the stock in the […] - 2025-08-20 02:22:51

9,047 Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) Acquired by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in Tyra Biosciences, Inc. (NASDAQ:TYRA – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund purchased 9,047 shares of the company’s stock, valued at approximately $84,000. Several other large investors have also recently bought and sold shares of the company. Rhumbline Advisers lifted its holdings in […] - 2025-08-11 05:32:50

Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $30.83 Consensus Price Target from Analysts

Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Free Report) have earned an average rating of “Buy” from the six ratings firms that are currently covering the firm, MarketBeat reports. Six analysts have rated the stock with a buy recommendation. The average 1-year target price among brokerages that have covered the stock in the last […] - 2025-07-04 02:00:53

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 10,426 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Tyra Biosciences, Inc. (NASDAQ:TYRA – Free Report) by 41.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,635 shares of the company’s stock after acquiring an […] - 2025-06-12 04:46:45

Two Sigma Investments LP Buys 7,093 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA)

Two Sigma Investments LP grew its stake in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA – Free Report) by 18.1% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 46,269 shares of the company’s stock after acquiring an additional 7,093 shares during the period. Two Sigma Investments LP’s holdings in Tyra Biosciences were worth $643,000 […] - 2025-06-09 04:24:51

Brokerages Set Tyra Biosciences, Inc. (NASDAQ:TYRA) Price Target at $30.83

Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Free Report) has earned an average rating of “Buy” from the six ratings firms that are covering the company, MarketBeat reports. Six analysts have rated the stock with a buy recommendation. The average 1 year price target among analysts that have issued ratings on the stock in the last […] - 2025-06-09 03:07:14

Head-To-Head Contrast: Tyra Biosciences (NASDAQ:TYRA) & CannTrust (OTCMKTS:CNTTF)

Tyra Biosciences (NASDAQ:TYRA – Get Free Report) and CannTrust (OTCMKTS:CNTTF – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings. Analyst Recommendations This is a summary of current […] - 2025-06-06 02:54:59

Deutsche Bank AG Buys 6,466 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA)

Deutsche Bank AG grew its stake in Tyra Biosciences, Inc. (NASDAQ:TYRA – Free Report) by 52.0% in the 4th quarter, Holdings Channel reports. The firm owned 18,909 shares of the company’s stock after purchasing an additional 6,466 shares during the period. Deutsche Bank AG’s holdings in Tyra Biosciences were worth $263,000 at the end of […] - 2025-06-02 04:42:58

Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $30.83 Average Price Target from Brokerages

Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Free Report) have received a consensus rating of “Buy” from the six brokerages that are currently covering the stock, MarketBeat.com reports. Six research analysts have rated the stock with a buy recommendation. The average 12 month target price among analysts that have covered the stock in the […] - 2025-05-15 02:20:56

Barclays PLC Purchases 5,445 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA)

Barclays PLC boosted its position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA – Free Report) by 14.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 43,070 shares of the company’s stock after purchasing an additional 5,445 shares during the period. Barclays PLC’s holdings […] - 2025-05-09 04:41:04

Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Consensus Recommendation of “Buy” by Brokerages

Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Free Report) have been assigned an average rating of “Buy” from the six analysts that are presently covering the stock, Marketbeat.com reports. Six investment analysts have rated the stock with a buy rating. The average twelve-month price target among analysts that have issued ratings on the stock […] - 2025-04-17 05:20:56

Vanguard Group Inc. Reduces Holdings in Tyra Biosciences, Inc. (NASDAQ:TYRA)

Vanguard Group Inc. lowered its position in Tyra Biosciences, Inc. (NASDAQ:TYRA – Free Report) by 3.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,207,765 shares of the company’s stock after selling 37,643 shares during the quarter. Vanguard Group Inc.’s holdings […] - 2025-04-17 04:22:50

US Bancorp DE Acquires Shares of 3,612 Tyra Biosciences, Inc. (NASDAQ:TYRA)

US Bancorp DE acquired a new stake in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 3,612 shares of the company’s stock, valued at approximately $50,000. Other institutional investors and hedge funds have also […] - 2025-03-19 05:14:54

China Universal Asset Management Co. Ltd. Takes Position in Tyra Biosciences, Inc. (NASDAQ:TYRA)

China Universal Asset Management Co. Ltd. acquired a new stake in Tyra Biosciences, Inc. (NASDAQ:TYRA – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 10,730 shares of the company’s stock, valued at approximately $149,000. Several other hedge funds and […] - 2025-02-04 06:53:07

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) TYRA holdings

Share Trades of TYRA by Blackrock for IE00BYXG2H39

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-10-06	BUY	267	13.430	13.770	13.736	USD 3,668	11.25
2025-10-03	BUY	623	13.660	13.920	13.894	USD 8,656	11.24
2025-10-02	BUY	89	13.390	13.650	13.624	USD 1,213	11.23
2025-09-30	BUY	178	13.990	14.020	14.017	USD 2,495	11.20
2025-09-26	BUY	178	12.970	13.060	13.051	USD 2,323	11.18
2025-09-25	BUY	178	12.540	12.760	12.738	USD 2,267	11.17
2025-09-24	SELL	-2,718	12.760	13.870	13.759	USD -37,397	11.16 Loss of -7,058 on sale
2025-09-18	BUY	98	12.790	12.865	12.857	USD 1,260	11.15
2025-09-17	BUY	294	12.150	12.690	12.636	USD 3,715	11.15
2025-09-11	SELL	-98	12.470	12.545	12.538	USD -1,229	11.12 Loss of -139 on sale
2025-09-10	BUY	196	11.910	12.420	12.369	USD 2,424	11.11
2025-09-05	SELL	-97	12.650	12.910	12.884	USD -1,250	11.09 Loss of -174 on sale
2025-08-29	SELL	-294	12.670	12.700	12.697	USD -3,733	11.06 Loss of -481 on sale
2025-08-27	BUY	194	12.880	12.960	12.952	USD 2,513	11.04
2025-08-26	SELL	-97	12.640	12.800	12.784	USD -1,240	11.03 Loss of -170 on sale
2025-08-25	BUY	97	12.000	12.610	12.549	USD 1,217	11.02
2025-08-20	SELL	-388	10.240	10.360	10.348	USD -4,015	11.02 Profit of 263 on sale
2025-08-18	BUY	194	10.810	11.240	11.197	USD 2,172	11.03
2025-08-08	SELL	-194	10.450	10.970	10.918	USD -2,118	11.05 Profit of 25 on sale
2025-08-05	BUY	96	11.450	11.720	11.693	USD 1,123	11.05
2025-08-01	SELL	-288	10.370	10.815	10.770	USD -3,102	11.06 Profit of 82 on sale
2025-07-30	BUY	384	11.150	11.660	11.609	USD 4,458	11.06
2025-07-17	SELL	-192	10.860	11.315	11.269	USD -2,164	11.07 Loss of -38 on sale
2025-07-11	SELL	-776	10.260	10.580	10.548	USD -8,185	11.09 Profit of 420 on sale
2025-07-07	BUY	291	9.610	10.024	9.983	USD 2,905	11.12
2025-07-02	BUY	5,335	10.050	10.400	10.365	USD 55,297	11.15
2025-06-25	BUY	194	9.630	9.750	9.738	USD 1,889	11.20
2025-06-20	BUY	2,760	9.230	9.753	9.701	USD 26,774	11.25
2025-06-11	BUY	176	10.180	10.925	10.851	USD 1,910	11.33
2025-06-10	BUY	178	10.710	11.040	11.007	USD 1,959	11.33
2025-06-04	SELL	-89	10.260	10.335	10.328	USD -919	11.37 Profit of 93 on sale
2025-04-23	BUY	88	10.020	10.440	10.398	USD 915	11.99
2025-04-10	SELL	-704	7.550	7.670	7.658	USD -5,391	12.45 Profit of 3,372 on sale
2025-04-08	SELL	-88	7.060	7.880	7.798	USD -686	12.60 Profit of 423 on sale
2025-04-07	SELL	-88	7.380	7.725	7.690	USD -677	12.69 Profit of 440 on sale
2025-04-04	SELL	-445	7.740	8.130	8.091	USD -3,600	12.77 Profit of 2,080 on sale
2025-04-01	BUY	360	8.720	9.410	9.341	USD 3,363	12.90
2025-03-31	SELL	-267	9.300	9.740	9.696	USD -2,589	12.96 Profit of 872 on sale
2025-03-21	BUY	2,099	10.690	11.050	11.014	USD 23,118	13.27
2025-03-14	SELL	-1,312	11.500	11.820	11.788	USD -15,466	13.51 Profit of 2,254 on sale
2025-03-07	SELL	-164	10.940	11.210	11.183	USD -1,834	13.83 Profit of 434 on sale
2025-03-04	SELL	-82	10.950	11.000	10.995	USD -902	14.04 Profit of 250 on sale
2025-02-25	BUY	164	12.030	12.900	12.813	USD 2,101	14.36
2025-02-19	SELL	-81	12.790	12.860	12.853	USD -1,041	14.55 Profit of 138 on sale
2025-02-13	BUY	243	12.250	12.570	12.538	USD 3,047	14.81
2025-02-12	BUY	81	12.040	12.335	12.306	USD 997	14.92
2025-02-11	BUY	324	12.130	12.740	12.679	USD 4,108	15.03
2025-01-17	BUY	320	16.190	16.600	16.559	USD 5,299	15.69
2025-01-16	BUY	320	16.150	16.640	16.591	USD 5,309	15.62
2025-01-10	SELL	-160	15.200	15.710	15.659	USD -2,505	15.46 Loss of -32 on sale
2025-01-08	SELL	-324	15.970	16.000	15.997	USD -5,183	14.43 Loss of -508 on sale

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TYRA

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy